Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
02196
02196
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
02196 News
HSI Rises 268 Points at Midday; BABA-W Jumps Over 3%; Pharmaceuticals in Demand
Jan 13 2026
aastocks
CLSA Raises FOSUN PHARMA (02196.HK) Price Target to $31.6 Following GLP-1 Drug Partnership with Pfizer
Dec 10 2025
aastocks
Fosun Pharma Partners with Pfizer for Exclusive GLP-1R Agonist License, Secures $150M Upfront Payment
Dec 09 2025
PRnewswire
Chairman Guo Guangchang: FOSUN INTL Aims to Leverage Global Industrial Strengths for Pioneering Innovation in China
Nov 06 2025
aastocks
Fosun Pharma Reports 25.5% Year-on-Year Increase in Net Profit to RMB 2.523 Billion for Q1-Q3
Oct 28 2025
aastocks
<Research>HSBC Updates Ratings and Price Targets for Pharma and Biotech Stocks (Table)
Oct 02 2025
aastocks
Citi Increases FOSUN PHARMA's Target Price to HKD35.3, Shifts Focus to R&D Revenue Opportunities
Sep 18 2025
aastocks
HSI Gains 19 Points at Midday; Pharmaceutical Stocks Soar; Automotive Sector Continues to Rise
Sep 16 2025
aastocks
M Stanley Upgrades FOSUN PHARMA (02196.HK) to Overweight, Predicting a Turnaround
Sep 09 2025
aastocks
Midday Update: HSI Ends at 25,508, Gaining 90 Points; HSTI Reaches 5,702, Up 15 Points; BABA Rises Over 3%; WUXI BIO, CHOW TAI FOOK, FOSUN PHARMA, HORIZONROBOT-W, and CHINA LESSO Achieve New Highs
Sep 08 2025
aastocks
HSI Declines 305 Points at Midday Due to Drops in Chip, Robotics, and Pharmaceutical Sectors
Sep 04 2025
aastocks
CLSA: FOSUN PHARMA (02196.HK) ESOP Boosts Growth Outlook; Price Target Raised to $29.6
Aug 28 2025
aastocks
FOSUN PHARMA Reports 39% Increase in Interim Net Profit to RMB 1.702 Billion; No Dividend Declared
Aug 26 2025
aastocks
<Research>CICC Expects Commercial Insurance Innovative Drug Catalog Adjustments to Help High-Value Innovative Drugs Land
Aug 13 2025
aastocks
FOSUN PHARMA Surges 7%+ at Open; Potential Value of Overseas Licensing for Small-Molecule Oral DPP-1 Inhibitor Totals USD645M
Aug 12 2025
aastocks
<H Shrs>HSI Loses 82Pts at Open; BABA-W Soft; FOSUN PHARMA Rebounds
Aug 12 2025
aastocks
Show More News
